Chronic sinusitis plays only a minor role in the development of head and neck cancer (HNC), reveals a recent research.
"Despite the fact that people with chronic sinusitis have an increased risk for certain subtypes of HNCs, the absolute risk of these cancers is low," said Daniel C. Beachler, Researcher at the National Cancer Institute, at Bethesda, in the US.
Acute sinusitis is a common inflammatory condition of the sinuses often caused by viral or bacterial infections. The condition is considered chronic when the episode persists longer than 12 weeks.
Chronic sinusitis may be involved in the cause of certain HNCs due to immunodeficiency or inflammation -- but not majorly, as recent research has found.
It was earlier associated with the risk of developing HNC, particularly nasopharyngeal cancer (NPC), human papillomavirus-related oropharyngeal cancer (HPV-OPC), and nasal cavity and paranasal sinus cancer (NCPSC).
The authors' findings, published by JAMA Otolaryngology, suggest that sinusitis-related inflammation or immunodeficiency plays a minor role in the development of these cancers.
For this study, the researchers used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and included 483,546 Medicare beneficiaries from SEER areas, and 826,436 who developed cancer (including 21,716 with HNC). Most individuals were female (58 per cent) with an average age of 73.
Most of this increased risk was limited to within one year of the chronic sinusitis diagnosis, as associations were largely reduced by one year or more after chronic sinusitis.
All the three HNC subtypes had cumulative incidence of less than 0.07 per cent eight years after chronic sinusitis diagnosis.
"The cumulative incidence of NPC, HPV-OPC, and NCPSC was less than 0.10 per cent after eight years of follow-up post a chronic sinusitis diagnosis," Beachler said.
--IANS
som/ss/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
